Modivigil 200mg Tablet contains Modafinil 200mg, a prescription wakefulness-promoting medicine. Modafinil is indicated to improve wakefulness in adults experiencing excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), and shift work disorder (SWD).

The 200mg strength is an established dosage strength of modafinil tablets and corresponds to the labeled recommended adult dosage for each of the three approved indications in the referenced prescribing information.

Product Information

What Is Modivigil 200mg?

Modivigil 200mg is an oral tablet containing Modafinil 200mg.

Modafinil is a centrally acting wakefulness-promoting medicine used in adults with excessive sleepiness associated with:

• Narcolepsy
• Obstructive Sleep Apnea (OSA)
• Shift Work Disorder (SWD)

For OSA, modafinil is indicated for the associated excessive sleepiness and not for treatment of the underlying airway obstruction. Appropriate treatment for the underlying OSA should continue as directed by a healthcare professional.

Modivigil 200mg Uses

Narcolepsy

Modafinil is indicated to improve wakefulness in adults with excessive sleepiness associated with narcolepsy.

Obstructive Sleep Apnea

Modafinil can be used to improve excessive sleepiness associated with obstructive sleep apnea.

It does not treat the underlying airway obstruction. If CPAP or another treatment has been prescribed for OSA, that treatment should continue according to medical advice.

Shift Work Disorder

Modafinil is also indicated to improve wakefulness in adults with excessive sleepiness associated with shift work disorder.

How Does Modivigil 200mg Work?

Modivigil contains modafinil, a wakefulness-promoting agent that acts on the central nervous system.

The precise mechanism by which modafinil produces its wakefulness-promoting effects has not been completely established. Modafinil affects neurotransmitter systems involved in the regulation of wakefulness.

Modivigil 200mg Dosage

Modivigil 200mg should be taken only according to the prescription and instructions provided by a qualified healthcare professional.

The current prescribing information lists the following adult regimens:

For narcolepsy and OSA, doses up to 400mg/day have been tolerated in studies, but there is no consistent evidence of additional benefit beyond 200mg/day.

The appropriate dosage for an individual patient should be determined by their healthcare professional.

For patients with severe hepatic impairment, the prescribing information recommends reducing the dose to half the recommended dose. Lower doses and close monitoring may also be appropriate for some elderly patients.